Tag - oxycontin

 
 

OXYCONTIN

Japan Times
COMMENTARY / World
Jul 30, 2021
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Japan Times
BUSINESS
Sep 16, 2019
After deluge of lawsuits, OxyContin maker Purdue Pharma files for bankruptcy protection
OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic.
Japan Times
BUSINESS
Sep 12, 2019
Purdue Pharma reaches tentative opioid settlement in deal worth up to $12 billion, will file for bankruptcy soon: sources
OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next week, people familiar with the matter said.
Japan Times
BUSINESS / Companies
Sep 4, 2019
OxyContin maker Purdue prepares 'free-fall' bankruptcy as settlement talks stall, sources say
OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three people familiar with the matter said, after some states balked at the company's $10 billion to $12 billion offer in August to end their lawsuits as part of a negotiated Chapter 11 case.
Japan Times
BUSINESS / Companies
Aug 28, 2019
Purdue Pharma discussing up to $12 billion offer to settle over 2,000 opioid claims and filing for bankruptcy
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.
Japan Times
WORLD / Science & Health
Aug 27, 2019
U.S. opioid ruling gives 'green light' for other lawsuits
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee.
BUSINESS
Dec 5, 2017
Montana sues OxyContin maker Purdue over opioid epidemic
Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

Longform

Historically, kabuki was considered the entertainment of the merchant and peasant classes, a far cry from how it is regarded today.
For Japan's oldest kabuki theater, the show must go on